Skip to main content

Table 1 Laboratory data (Blood. Age 36 years)

From: Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant

Variables

Values

Normal range

Fasting glucose, mmol/l

8.8

3.1–6.1

HbA1c, %

7.3

4–6

C-peptide, ng/ml

0.928

1.1–4.4

Anti-tyrosine phosphatase antibodies, U/ml

0.144

neg. < 8

Anti-islet cell antibodies, U/ml

0.58

neg. < 0.95

Anti-insulin antibodies, U/ml

17

pos. > 10

Zinc transporter 8 antibodies, U/ml

1.436

neg. < 15

Anti-GAD antibodies, U/ml

0.7

neg. < 1

Total cholesterol, mmol/l

5.55

3.3–5.2

HDL cholestrol, mmol/l

0.452

1.15–2.6

LDL cholestrol, mmol/l

1.435

1.1–3

Triglycerides, mmol/l

8.14

0.1–1.7

Leptin, ng/ml

5.382

3.7–11.1

Adiponectin, ng/ml

2.54

8.2–19

Creatinine kinase, U/l

472

29–168

ALT, U/l

42

0–55

AST, U/l

75

5–34

GGT, U / l,

139

9–36

Calcium, mmol/l

2.28

2.15–2.55

Ionized calcium, mmol/l

0.9

1.03–1.29

Vitamin D, ng / ml

27.2

> 30

Creatinine, mcmol/l

69.2

50–98

CKD – EPI, ml/min/1,73 m2

98

90–120

Urea, mmol/l

9.4

2.5–6.7

Uric acid, μmol

444.25

142–339

  1. HbA1c Hemoglobin A1c, GAD Glutamic acid decarboxylase, HDL High-density lipoprotein, LDL Low-density lipoprotein, ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT Gamma-glutamyl transpeptidase, CKD – EPI Chronic Kidney Disease Epidemiology Collaboration